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without (P<0.01). COX proportional hazards model of multi-factor analysis showed
that increased PTX3 was an independent risk factor for adverse cardiovascular
events in patients with chronic heart failure (relative risk (RR)¼4.224, P<0.01; 95%
CI 1.130-15.783).
Conclusions: PTX3 levels were positively and signiﬁcantly associated with the
severity of heart failure. Chronic heart failure patients with increased PTX3 had a
higher risk of developing adverse cardiovascular events. Increased PTX3 was
probably the long-term independent predictor for patients with chronic heart
failure.
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Objectives: To evaluate the effects of a single dose of Ginkgo biloba extract on the
parameters of prothrombotic state (PTS).
Methods: Database including MEDLINE, EMBASE, Cochrane Library, The
Cochrane Central Register of Controlled Trials, Chinese Biomedical Literature
Database (CBM), China National Knowledge Infrastructure (CNKI) and Wanfang
Data were searched from inception to April 2014. Randomized controlled trials
(RCTs) involving the healthy volunteers or patients receiving ginkgo biloba extract as
compared with placebo were included. Parameters of the prothrombotic state
including: platelet aggregation, activated partial thromboplastin time (APTT), pro-
thrombin time (PT), plasma ﬁbrinogen, blood viscosity, blood ﬂow velocity. Risk of
bias of allocation sequence, allocation concealment, blinding, incomplete outcome
data, selective outcome reporting, and other biases were assessed by the Cochrane risk
of bias assessment tool. The data was analyzed by the Cochrane collaboration’s
RevMan 5.0. The following statistical methods were used: weighted mean difference
(WMD), standardized mean difference (SMD) and 95% conﬁdence intervals (CIs).
The results of the heterogeneity of the included studies were statistically homogeneous
(P>0.1, I2 <50%), the ﬁxed effect model was used for Meta analysis; there is sta-
tistical heterogeneity such as the testing results (P<0.1, I2>50%), then ﬁnd out the
heterogeneous sources according to the sensitivity analysis, subgroup analysis or
meta-regression analysis.
Results: Fourteen RCTs from ten countries with 440 participants were analyzed.
Ginkgo biloba extract group has signiﬁcant improvements in the partial parameters of
prothrombotic state as compared with placebo group. The result showed that Aden-
osine 5’-diphosphate (ADP)-induced platelet aggregation was signiﬁcantly inhibited
[WMD -7.53%, 95%CI (-14.27, -0.78), P¼0.03], the blood viscosity was signiﬁcantly
reduced [WMD-1.40mPa$s, 95%CI (-1.91, -0.89), P<0.00001], and the blood ﬂow
was increased [SMD 0.63, 95%CI (0.17, 1.09), P¼0.008]. However, there were no
signiﬁcant differences observed between GBE and placebo treatments in APTT
[WMD -0.25s, 95% CI (-0.68, 0.19), P¼0.26], PT [WMD -0.07s, 95% CI (-0.37,
0.23), P¼0.64], plasma ﬁbrinogen [WMD -4.94 mg/dl, 95% CI (-23.02, 13.15),
P¼0.59].
Conclusions: Based on the result of Meta-analysis about the parameters of pro-
thrombotic state, Ginkgo biloba extract may signiﬁcantly reduce blood viscosity and
also increase blood ﬂow velocity as compared with placebo. GBE may signiﬁcantly
improve the partial parameters of prothrombotic state and inhibit the formation of
thrombus.
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Objectives: Cardiac hypertrophy is an independent risk factor for cardiovascular
disease and its subsequent progression to heart failure represents a major cause of
morbidity and mortality all over the world. Chlorogenic acid (CGA) is an important
component of Chinese herbal medicine, which has a wide range of biological activity,
but the effct of CGA on heart in vivo is still unclear. The purpose of this research is to
investigate that whether CGA has a protective effect on isoproterenol-induced
myocardial hypertrophy in mice in vivo.
Methods: Mice were subcutaneously injected with normal saline or 1, 5and 10mg/
kg/day CGA for 3 days, and the next day treated with normal saline or 30mg/kg/
day isoproterenol for 7 days. All mice were detected by Vevo 770 ultrasonic
diagnostic apparatus. Both heart weight and body weight were measured in the
end. Both left ventricle and heart were made into Parafﬁn sections which were
stained by HE.
Results: In 5 and 10 mg/kg/day CGA groups EF value and FS value were signiﬁ-
cantly increased, however the heart weight index is signiﬁcantly decreased comparing
with normal saline group. According to the biopsy, left ventricular posterior wall
(LVPW) in experimental group decreased and cardiac chambers became larger
comparing with normal saline group.
Conclusions: This study mainly reveals that CGA is helpful to heart, and it has a
signiﬁcant protective effect on myocardial hypertrophy in vivo.JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/EGW25-e4202
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Objectives: Heart failure (HF) affects many people worldwide, and it is generally
expected that the number of people with HF will increase because of the aging
population and better survival rates of patients after a myocardial infarction. Read-
mission rates usually vary between 25% and 50% within 6 months after the ﬁrst
hospitalization for HF and account for approximately 70% of the costs. Despite efforts
to improve outcomes in heart failure (HF), readmission rates remain relatively high.
Reasons for readmission from different perspectives (patient, caregiver, health care
providers) may help to optimize the future management of patients with HF. The aims
of this study are to :1) gain insight into reasons for HF readmission from the
perspective of patients, caregivers, cardiologists, and HF nurses; 2) examine simi-
larities and differences in perspectives on the reason for an HF readmission, and 3)
describe possibilities to prevent an HF readmission from different perspectives.
Methods: A descriptive design was used with data from a substudy of the Coordi-
nating study evaluating Outcomes of Advising and Counseling in Heart failure
(COACH), a multicenter study on the effects of education and counseling in HF.
Between November 2010 and May 2013, 918 patients from the ﬁrst hospiltal of Jilin
Univercity were included in the COACH study. Inclusion criteria were hospitalization
for symptomatic HF, conﬁrmed by the cardiologist, and underlying heart disease as the
cause of HF. Exclusion criteria were an invasive intervention within the last 6 months
or planned in the next 3 months, participation in a study requiring additional visits to a
research nurse, and evaluation for heart transplantation. After written informed consent
to participate in the study, patients were followed for a period of 18 months. Patients
were randomized to 1 of 3 study groups: basic support, intensive support, or control.
Results: Data on reasons for readmission were collected on 173 readmissions. Per-
spectives of patients, caregivers, cardiologists, and HF nurses were collected by
interview and questionnaire. Worsening HF as the sole reason for readmission was
reported most often; however, 36% of caregivers, 56% of patients, and 63% to 65% of
health care providers indicated that other factors, such as comorbidity, nonadherence,
and nonoptimal medication, were important contributing factors. In only 34% of
readmissions, patients and their caregivers agreed with health care providers on the
underlying reason. Respondents reported that 23% to 31% of the readmissions could
probably have been prevented if adherence were higher, patients requested help
earlier, and adequate multidisciplinary professional help were available.
Conclusions: Firstly, to prevent future readmissions of patients with HF, it is
important to fully understand the reasons for readmission by gaining insight on the
reason for readmission from different perspectives. Adding information from different
perspectives provides a complete picture of reasons for the adverse outcome. Secondly,
we may need another approach to prevent adverse outcomes in which other medical
problems and new strategies, such as telemedicine or other home-based interventions
to improve adherence have to be considered. Finally, insufﬁcient professional help,
nonadherence, and knowledge deﬁcit were reported moreoften in the control group as a
precipitating factor for readmission than in the intensive treatment group.
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Objectives: Recent studies have shown that NAFLD may be closely related with
CAS. In this research, By measuring the visceral fat thickness (VFT), it include the fat
of epicardial, before the liver, Around the kidney, Next to the kidney, and evaluating
the severity of CAS (according to coronary angiography), we want exploring the
relationship between NAFLD, VFT and the severity of CAS.
Methods: (1) The relationship between NAFLD, VFT and severity of CAS (323). By
coronary angiography, the subjects were divided into three groups as bellow, the
normal group (without stenosis), the moderate stenosis group (the target lesions less
than 75%), the severe stenosis Group (the target lesions more than 75%).The number
and VFT of each group in NAFLD patients were measured. (2) The correlation be-
tween NAFLD and VFT in the severe stenosis group (197). The severe stenosis group
was divided into two groups that NAFLD group and non NAFLD group, according to
coronary score, each group was divided into 3subgroups (3-6, 6-10, more than 10
points). The VFT of each group was measured.
Results: (1) Along with the increasing degree of CAS, the proportion of NAFLD was
signiﬁcantly increased by 16% and 19% (the moderate stenosis was 71%, the severe
stenosis was 74%) than in the normal group(without coronary artery stenosis was
55%), the total VFT also increase, especially the epicardial layer (the moderate ste-
nosis increased by 23% and the severe stenosis increased by 54%). (2) In the severe
CAS group, the patients were divided into NAFLD group and non NAFLD group.
compared with non NAFLD group, the fat of epicardial, before the liver, Around the
kidney, Next to the kidney and the coronary score signiﬁcantly increased in the
NAFLD group (10%, 22%, 32%, 36% and 27%, respectively) .Along with the in-
crease of coronary score , the epicardial fat thickness was increased signiﬁcantly (16%
and 34%, respectively) in the non NAFLD group; but the epicardial thickness of the
NAFLD group was slightly increased (8% and 8%, respectively). In the two groups,
the VFT of the other three sections have no signiﬁcant change among the subgroups.pidemiology, Prevention and Control C105
